CN115887395A — 恩杂鲁胺固体分散体制剂及其制备方法和应用
Assigned to Shanghai Yaotan Pharmaceutical Research And Development Co ltd · Expires 2023-04-04 · 3y expired
What this patent protects
本发明公开了一种恩杂鲁胺固体分散体制剂及其制备方法和应用。本发明的恩杂鲁胺固体分散体制剂含有恩杂鲁胺固体分散体和药学上可接受的赋型剂,其中,所述恩杂鲁胺固体分散体包含恩杂鲁胺、载体和表面活性剂,所述恩杂鲁胺与所述载体的质量比为1∶1.0~3.0;所述载体为醋酸羟丙甲基纤维素琥珀酸酯和/或聚甲基丙烯酸酯。该制剂溶出度高、溶出速度快、稳定性好、载体用量较低,且制备工艺简单、有机溶剂可回收利用、生产成本低。
USPTO Abstract
本发明公开了一种恩杂鲁胺固体分散体制剂及其制备方法和应用。本发明的恩杂鲁胺固体分散体制剂含有恩杂鲁胺固体分散体和药学上可接受的赋型剂,其中,所述恩杂鲁胺固体分散体包含恩杂鲁胺、载体和表面活性剂,所述恩杂鲁胺与所述载体的质量比为1∶1.0~3.0;所述载体为醋酸羟丙甲基纤维素琥珀酸酯和/或聚甲基丙烯酸酯。该制剂溶出度高、溶出速度快、稳定性好、载体用量较低,且制备工艺简单、有机溶剂可回收利用、生产成本低。
Drugs covered by this patent
- Xtandi (enzalutamide) · Astellas Pharma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.